BBC Studios Aims to Reclaim ‘Doctor Who’ as Franchise Faces Uncertain Future
The future of ‘Doctor Who’ has been a hot topic for months, especially after the sci-fi institution lost both its showrunner and streaming partner in quick succession. Fans are left wondering who might take the helm of the TARDIS next, particularly following the cancellation of a planned holiday special. Now, a new development indicates that a familiar name is eager to return to the driver’s seat.
The corporation’s commercial arm produced ‘Doctor Who’ for most of its run before the latest era shifted production to Sony-owned Bad Wolf, a partnership that also involved Disney+ as a co-financier. This arrangement fell apart when Disney exited and showrunner Russell T Davies stepped back from the franchise he had guided through two revivals. The show has been airing on the British broadcaster since 1963, and its 2026 Christmas special was quietly canceled due to this upheaval.
This upheaval prompted the BBC to put ‘Doctor Who’ out to tender, with a launch date likely a couple of years away. Stepping into this opening is BBC Studios boss Tom Fussell, who confirmed in a recent interview that his company intends to compete for the rights to produce the show once again. As noted in a post shared by Deadline, Fussell emphasized that BBC Studios is not sitting this one out, declaring the company is in it to win it.
Fussell did not specify which BBC Studios label would produce the series or if multiple labels within the company will compete against each other for the job. He did stress that the company’s institutional knowledge of the franchise gives it a unique advantage. He explained that as the distributor and commercial licensor of ‘Doctor Who’, BBC Studios understands fan relationships and can build upon that, adding that the show is something people within the organization care deeply about.
These comments coincided with the BBC’s annual report, which noted that larger competitors now pose a challenge to BBC Studios following significant consolidation across the UK media landscape.
Sky’s acquisition of ITV and the merger of All3Media with Banijay have both expanded the reach of rival production giants. Fussell, who experienced a similar merger earlier in his career, offered a pointed perspective on this trend. He stated that mergers typically occur when a market lacks growth, and executives start pursuing the dreaded word synergies, which he referred to as a more palatable term for job cuts.
Despite this competitive pressure, BBC Studios reported strong numbers, with revenue rising to 2.2 billion pounds and EBITDA increasing by 17 percent, positioning the company to meet its five-year financial return target to the BBC. New Director General Matt Brittin also commented on the franchise’s prospects, describing ‘Doctor Who’ as a series that has regenerated multiple times over its 60-plus-year history and will do so again—a statement that will likely reassure a fanbase still processing significant changes.
Whether BBC Studios ultimately secures the production rights remains to be seen, as other production companies are expected to submit their own pitches before a decision is made. For a franchise built entirely around reinvention, this behind-the-scenes competition feels almost fitting. Do you think BBC Studios deserves to reclaim ‘Doctor Who’, or would you prefer to see a fresh production company take the Doctor into its next era?
